 |
|
|
Washington University in St. Louis
School of Medicine |
|
|
|
Study Director
D. Ashley Hill, M.D., Assistant Professor of Pathology and Immunology and of Pediatrics. Dr. Hill is a pediatric pathologist with a primary interest in the developmental basis of pediatric embryonal neoplasms. She serves as the Director of Pathology Operations for the International Pleuropulmonary Blastoma (PPB) Registry and is a key participant in developing the scientific mission of the Registry. |
|
| |
|
| |
|
|
|
| |
 |
Study Coordinator
Jennifer Ivanovich, M.S., M.B.A., Manager, Hereditary Cancer Core, Alvin J. Siteman Cancer Center Genetics. Ms. Ivanovich is a genetics counselor and established investigator in the field of hereditary cancer. She works with families who have rare tumors and hereditary cancer syndromes. |
|
| |
|
| |
|
|
|
| |
 |
Dr. Alison Whelan, M.D., Co-Director, Alvin J. Siteman Cancer Center Hereditary Cancer Core Associate Professor of Medicine, Division of Medical Genetics.Dr. Whelan is an established investigator in the field of medical genetics with a particular expertise in identification and risk assessment methods for individuals at heightened cancer risk due to heritable predisposition. |
|
| |
|
|
|
| |
 |
Dr. Mark Watson, M.D., Ph.D., Director, Alvin J. Siteman Cancer Center Multiplexed Gene Analysis Core and Tissue Procurement Core Associate Professor of Pathology and Immunology. Dr. Watson has extensive expertise in the use of microarray technology to apply to problems in diagnostic and therapeutic medicine.
|
|
| |
|
|
|
| |
 |
Dr. Paul Goodfellow, Ph.D., Leader, Alvin J. Siteman Cancer Center Cancer Genetics Program, Co-Director, Alvin J. Siteman Cancer Center Hereditary Cancer Core Professor, Departments of Surgery, Genetics and Obstetrics and Gynecology.
Dr. Goodfellow is an expert in the molecular genetics of human malignancies with an interest in devising strategies for identification of patients at high risk for common cancers. |
|
| |
|
|
|
| |
 |
Dr. Louis P. Dehner, M.D., Professor, Pathology and Immunology and Pediatrics and Director, Division of Anatomic Pathology.
Dr. Dehner is a pathologist with expertise in pediatric neoplasia. He and his colleagues were the first to recognize PPB as a distinct clinicopathologic entity. He has devoted great effort to improving our understanding of the pathology and pathogenesis of PPB. He serves as a central pathology reviewer for the PPB Registry. |
|
| |
|
|
|
| |
Children’s Hospitals and Clinics of Minnesota
and the International PPB Registry |
| |
|
| |
 |
Dr. Jack Priest, M.D., Research Director, International Pleuropulmonary Blastoma Registry. Dr. Priest is a pediatric oncologist who is recognized as the expert on the clinical aspects of pleuropulmonary blastoma.
www.ppbregistry.org |
|
| |
|
|
|
